Next, by establishing the humanized microbiome mice with feces from newly diagnosed CRC patients, we found that the disturbed gut microbiota from CRC patients were sufficient to result in the poor response to anti-PD-1 mAb. The gene discussed is PDCD1; the disease is colorectal carcinoma.